Ji-Yao Wang, Jin-Sheng Guo, Chang-Qing Yang

Ji-Yao Wang, Jin-Sheng Guo, Chang-Qing Yang, Division of Gastroenterology, Zhongshan Hospital, Fu Dan University, Shanghai 200032, China
Supported by National Fund of Natural Science of China, NO. 39570336
Correspondence to: Ji-Yao Wang, M.D. MSc, Chief of Division of Gastroenterology, Zhongshan Hospital, Fu Dan University, 180 Feng Lin Road, Shanghai 200032, China. jiyao_wang@hotmail.com
Telephone: +86-21-34140200 Fax: +86-21-34160980
Received 2002-04-13 Accepted 2002-05-10


Abstract
AIM: The present study was conducted to test the hypothesis that the introduction of the collagenase gene into tissue culture cells and into a rat model of liver fibrosis would result in the expression of enzymatically active product.

Methods: FLAG-tagged full-length rat collagenase cDNA was PCR amplified and cloned into a mammalian expression vector. NIH3T3 cells were then transiently transfected with this construct. Expression of exogenous collagenase mRNA was assessed by RT-PCR, and the exogenous collagenase detected by Western blotting using anti-FLAG monoclonal antibody. Enzymatic activity was detected by gelatin zymography. To determine the effects of exogenous collagenase production in vivo, the construct was bound to glycosyl-poly-L-lysine and then transduced into rats that had developed liver fibrosis as a result of CCl4 plus ethanol treatment. The hepatic expression of the construct and its effect on the formation of liver fibrosis were demonstrated using RT-PCR and immunohistochemistry.

RESULTS: It was found that exogenously expressed rat collagenase mRNA could be detected in NIH3T3 cells following transfection. Enzymatically active collagenase could also be detected in the culture medium. The recombinant plasmid was also expressed in rat liver after in vivo gene transfer. Expression of exogenous rat collagenase correlated with decreased deposition of collagen types I and III in the livers of rats with experimentally induced liver fibrosis.

CONCLUSION: The expression of active exogenous rat collagenase could be achieved in vitro and in vivo. It was suggested that in vivo expression of active exogenous collagenase may have therapeutic effects on the formation of liver fibrosis.

Wang JY, Guo JS, Yang CQ.Expression of exogenous rat collagenase in vitro and in a rat model of liver fibrosis.
World J Gastroenterol 2002; 8(5):901-907



INTRODUCTION
Matrix metalloproteinases (MMPs) are a group of proteolytic enzymes that require zinc ions for their activities, they take part in a variety of normal and disease-associated matrix lysis and remodeling events^[1-3]. For example, interstitial collagenase, one member of MMPs, also called collagenase, mainly initiates the degradation of collagen types I, II, III, V, VII, and X, which are fibrillar collagens^[4-6]. Interstitial collagenase probably contributes importantly to tissue repair, embryogenesis, bone renewal, and to some pathogenic processes such as rheumatoid arthritis, tumor metastasis, and also organ fibrosis^[7-10]. Changing the expression or the activities of interstitial collagenase by regulatory factors or by gene transfer may have therapeutic effects on those disease processes.
      Liver cirrhosis often shortens life expectancy and decreases the quality of life. In liver cirrhosis, a major pathological feature is the accumulation of extracellular matrix (ECM). Within the major components of ECM, collagen types I and III constitute more than 95 % of the total content of increased collagen in fibrotic liver. The abnormal accumulation of ECM may reflect alterations in the synthesis of matrix proteins, their degradation, or both^[11,12]. The reversibility of liver fibrosis/ cirrhosis has been found in patients with various chronic hepatopathy^{[13, 14]} and in experimental cirrhotic animals^[15], indicating a therapeutic approach of this disease condition through improving ECM degradation. It has been reported that the mRNA transcription of interstitial collagenase is not up-regulated in experimental hepatic fibrosis^[16,17] and the interstitial collagenase proteins in cirrhotic human livers and in serum of chronic hepatitis patients decrease^[18,19]. Previous study also shows that the activity of collagenase decreases in advanced liver fibrosis^[20-22] and in serum from patients with chronic liver disease^[23,24]. Therefore, we proposed that exogenous gene expression of active collagenase might have therapeutic effects on the chronic liver diseases processes. The present experiments were performed to test the hypothesis that the introduction of a collagenase expression vector into tissue culture cells resulted in the enzyme expression, and that similar introduction of exogenous collagenase into a rat model of chemically induced liver fibrosis, altered the development of fibrosis. The in vitro results suggest that rat collagenase could be transiently expressed in NIH3T3 cells, and that rat liver fibrosis could be delayed by transducing the collagenase gene in vivo.

MATERIALS AND METHODS
Vector construction
A 6 amino acids deleted rat collagenase cdna containing plasmid (UMR5.4) was kindly provided by Dr John J. Jeffrey^[25] and used as starting material. Full-length rat collagenase cDNA was PCR amplified using the primers RIC-UP1 and RIC-DP1 with UMR5.4 as the DNA template (Table 1). The sense primer RIC-UP1 contained the sequences of the deleted 6 amino acids. The PCR fragments were then inserted into the PCR2.1 vector (Invitrogen, Carlsbad, CA, USA) to form PCR2.1-RIC. Using PCR2.1-RIC as template, the cDNA was further PCR amplified with RIC-UP2 and RIC-DP2 as primers (Table 1). The FLAG epitope was added to the C-terminus of the rat collagenase gene in this construct by using RIC-DP2 that contained the FLAG sequence at the 3'end adjacent to the translation stop codon TAA (Table 1). The PCR reaction was performed as follows: the total reaction volume was 100 ml which contained 1ng DNA template (PCR2.1-RIC), 10 pmol.L^-1 of each primer of RIC-UP2 and RIC-DP2, 2.5 mmol.L^-1 dNTP, 10×PCR buffer and 5U Taq polymerase; 35 PCR cycles at 95 ℃ for 1.5 min, 55 ℃ for 1.5 min, and 72 ℃ for 2 min. The 1400 kb PCR product was purified and inserted into mammalian expression vector pTarge^TM by the method of TA cloning following the protocol suggested by manufacture (Promega, Madison, Wis, USA) and named as pcmv-RC-F (Figure 1, Map of the plasmid pcmv-RC-F). The pCMV-RC-F was DNA sequenced using T7 primer. The large-scale of plasmid DNA was prepared using Qiagen tip100 (Qiagen, Hilden, Germany). The vector pTargeTM that was self-ligated without any inserted DNA was also isolated and used as control in the transfection study.

Table 1 Primer pairs for PCR and RT-RCR reactions

( ): binding location of primer in relative cDNA sequence

Figure 1 Map of plasmid pCMV-RC-F. The FLAG tagged full length rat collagenase cDNA was inserted into a mammalian expression pasmid vector PtargeTM which carries the human cytomegalovirus (CMV) immediate-early enhancer/promoter region.

In vitro transfection
Exponentially growing NIH 3T3 cells were seeded into 6-well tissue culture dishes at 5×10⁵ cells/well and grown overnight to 60 % confluency in culture medium supplemented with 10 % FCS. Each well was then transfected with 5 mg DNA constructs using lipofectamine according to the instruction provided by the manufacturer (Gibico BRL, Eggenstein, Germany). Encapsulated DNA was incubated for 5 h on cells in serum free medium, then in medium containing 10 % bovine serum. After further incubation of the cells for 24 h, the culture medium was discarded and replaced by normal culture medium. Fifty-six h after transfection, the NIH 3T3 cells and their media were harvested for further analysis.

RT-PCR analysis for mRNA expression
The collected cells were washed twice with ice-cold phosphate-buffered saline (PBS), and the mRNA extracted with mrna Capture Kit (Boehringer Mannheim). The samples were further incubated with biotin-labeled oligo (dt) 20 working solution for 5 min to hybridize the mRNA with oligo (da)n. The mixture was added to a streptavidin-coated PCR tube, and incubated for 3 min at 37 ℃ to immobilize the poly (A)n rna. Tubes were then washed three times and amplified by RT-PCR. The RT-PCR reaction system contained 0.3 mmol.L^-1 each of the primer pairs RIC-UP3 and RIC-DP3 (corresponded to nucleotides 785-808 of the collagenase encoding region and the FLAG domain coding region, amplificated a PCR product of 652 bp), 5 mmol.L^-1 DTT, 6 U RNAsin, 1.5 mmol.L^-1 MgCl₂, 5×RT-PCR buffer and 1 ml Titan^TM Enzyme mix provided with the Titan^TM rt-PCR System (Boehringer Mannheim). Samples were placed in a thermocycler equilibrated at 50 ℃ for 30 min, at 94 ℃ for 5 min, then for 34 cycles at 94 ℃ for 1 min, 55 ℃ for 2 min, and 72 ℃ for 3 min, with a final extension at 72 ℃ for 10 min. The amplification products were then analyzed on 10 g.L^-1 agarose gels containing 0.5 mg.L^-1 ethidium bromide.

Western blot analysis of FLAG-tagged rat collagenase expression
The amount of protein in the collected culture medium of transfected cells was determined with Dye-binding method (Bio-Rad, Hercules, CA, USA). For each samples 30 mg total protein was electrophoresed on sodium dodecyl sulfate-polyacrylamide gel and then transferred to polyvinylidene difluoride (PVDF) membrane (Gelman Inc, Ann Arbor, MI, USA) by electroblotting. Pre-stained rainbrow recombinant protein molecular weight markers (Amersham International plc, Little Chalfont, Buckinghamshire, England) were used for molecular weight determinations. Membranes were blocked with a blocking buffer containing 50 g.L^-1 non-fat milk powder, 10 mmol.L^-1 Tris/HCl (pH 7.5), 100 mmol.L^-1 NaCl and 1 g.L^-1 Tween 20 and incubated with 1:100 diluted solution of anti-FLAG M₂ McAb^[26] (Kodak, New Haven, CT, USA) at 37 ℃ for 1 h. After washing for 30 min the membranes were treated with HRP-conjugated secondary antibody (1:5000) (Bio-Rad) for 1 h at room temperature followed by another 30 min of washings. The ECL Western blotting system (Amersham Life Sciences) was used in accordance to the manufacturer's  instructions for chemiluminescence of proteins, and the blots were then exposed to photographic films (Fuji Photo Film Co., Tokyo, Japan).

Gelatin zymography assay for the enzyme activity
The activity of collagenase was detected by gelatin zymography as previously described^{[27, 28]} with minor modifications. Culture supernatants that contained 60 mg /lane total protein were prepared and mixed with 5× zymogram sample buffer consisting of 0.4 mol.L^-1 Tris (pH 6.8), 50 g.L^-1 SDS, 200 g.L^-1 glycerol, and 0.3 g.L^-1 bromphenol blue, then electrophoresed with protein molecular weight markers as described before on 100 g.L^-1 sodium dodecyl sulfate-polyacrylamide gels containing 10 g.L^-1 gelatin under an ice water cycle. After electrophoresis, the position of molecular weight markers were marked and the gels were rinsed in washing buffer consisting of 50 mmol.L^-1 Tris, pH 7.6, 1 mmol.L^-1 ZnCl₂, 5 mmol.L^-1 CaCl₂, 250 g.L^-1 TritonX-100 at 4 ℃ on a rotary shaker. The Triton X-100 solution was decanted and replaced with rinsing buffer consisting of 50 mmol.L^-1 Tris (pH 7.6), 1 mmol.L^-1 ZnCl₂, 5 mmol.L^-1 CaCl₂ for further washing. The gel was then incubated with enzyme buffer containing 50 mmol.L^-1 Tris (pH 7.6), 1 mmol.L^-1 ZnCl₂, 5 mmol.L^-1 CaCl₂, 0.2 g.L^-1 Brij-35 at 37 ℃ for 42 h. Each gel was stained with 0.5 g.L^-1 Coomassie blue G-250 in an aqueous solution of 300 g.L^-1 methanol and 100 g.L^-1 acetic acid and destained with three changes of 300 g.L^-1 methanol, 100 g.L^-1 acetic acid. Areas of digestion were visualized as non-staining regions of the gel and photographed.

Animal model of liver fibrosis
Thirty-six male Wistar rats (Shanghai Experimental Animal Center, Chinese Academy of Sciences) weighing 130±10 g were randomly distributed into four groups, 6 in a normal control group (A), 10 in an experimental liver fibrosis model without plasmid treatment as disease control group (B), and 10 in each of two pcmv-RC-F plasmid transfection as treatment groups (C1 and C2). Animals in the normal control group were treated with olive oil and received food and water ad libitum. Rats in the other three groups received a subcutaneous injection of CCl₄ solution (500 g.L^-1 in olive oil) twice a week for eight weeks at a dose of 0.3 ml per 100 g of body weight after an initial dose of 0.6 ml per 100 g. The only source of fluid for the rats was 100 g.L^-1 ethanol in water during the entire period of experiment. In addition, animals in the C1 group were intravenous injected with of 100 mg of galactosyl poly-L-lysine (G-PLL, obtained from Dr. Wen Shouming, The Air Force General Hospital of Chinese Peoples Liberation Army, Beijing, China) encapsulated recombinant plasmid through tails vein every two weeks, beginning two weeks after the start of treatment with CCl₄. G-PLL was included to accelerate the targeting effect of the transduced plasmid to the livers^[29-31]. Animals in the C2 group received the same treatment as those in group C1 but the plasmid was administrated four weeks after starting the treatment with CCl₄. Animals in the B group received G-PLL encapsulated pTarge^TM empty plasmid vector at the same dosage and the same time as those in the C1 group. The molecular ratio of galactose and poly-L-lysine is 15:28 and the average molecular weight of the G-PLL is M _r 8 500.
      After weeks 8 treatment, the surviving 6 or 7 rats in each of the C1, C2, B groups and all the 6 rats in the A group were narcotized with 20 g.L^-1 pentobarbital sodium. The middle lobes of the livers were removed and specimens were fixed in Carnoy's fixative (glacial acetic acid, chloroform, and ethanol in volume ratio of 1:3:6) and then embedded in paraffin for histological analysis. The remaining tissue was quickly partitioned and immediately frozen and stored under liquid nitrogen for RNA extraction and RT-PCR analysis. Then the animals were humanly killed.

Collagenase mRNA expression in rat liver
Total RNA was isolated from the liver tissues using Trizol (Gibco BRL) according to the manufacturer's  directions. Integrity of RNA was confirmed by visual examination on an ethidium bromide-stained 10 g.L^-1 Tris-acetate and EDTA agarose gel. Total RNA of 1 mg from each sample was used for reverse transcription and amplification using a RT-PCR kit (Sino-American Biotechnology Co. Shanghai. China). The RT-PCR reaction contained 10 pmol each of the primer pairs RIC-UP3 and RIC-DP3 for detecting the recombinant collagenase mRNA (a product of 652 bp), or each primer pairs of IC-UP4 and IC-DP4 (designed within nucleotides 711-734 of the coding region and nucleotides 1440-1463 of 3'untranslated region of collagenase, Table 1) for amplifying the endogenous collagenase mRNA (a product of 753 bp)^[25]. The later primer pairs could not amplify the expression of recombinant collagenase that was lack of the nature 3'untranslated region of collagenase gene. Additionally primer pairs b-UP5 and b-DP5 were included for amplifying the expression of b-actin 335 bp DNA fragment) as internal control^[32]. Samples were placed in a thermocycler with the incubation programme of 37 ℃ for 40 min, 94 ℃ for 7 min, then 36 cycles of 94 ℃ for 1 min, 56 ℃ for 1 min, and 72 ℃ for 1 min, with a final extension of 72 ℃ for 10 min. Products of RT-PCR were electrophoresed on a 20 g.L^-1 agarose gel to show the amplified bands.

Histology and Immunohistochemistry
For immunohistochemical staining, 5 mm sections of each group were treated with anti-FLAG M₂ McAb to assay the expression of recombinant collagenase. After dewaxed with xylene and rehydrated through a graded alcohol series, sections were digested with 4 g.L^-1 trypsin. Nonspecific binding was blocked with calf serum 1:5 in PBS. The sections were incubated with mouse anti-FLAG M2 McAb (1:100) overnight at 4 ℃ and then with biotinylated horse anti-mouse IgG (Vector) for 30 min, avidin-peroxidase complex for 30 min, and the substrate solution (3,3-diaminobenzidine tetrahydrochloride in H₂O₂ in Tris buffer, pH 7.4) for 10 min, followed by counterstaining with hematoxylin. The sections were washed with 0.01 mol.L^-1 PBS (pH 7.4) three times after each step. Finally, ten high power fields of each section were observed under microscope and the positive signals were counted.
      Some sections of each group were treated with the monoclonal antibodies against collagen types I and III (1:100), then with secondary antibody and the procedure of the immunostaining were same to the above-mentioned except without counterstaining with hematoxylin. The slides were then analyzed with an Image Analyzing system (TJTY 300 System) to obtain the integral light density (ILD) of stained collagen types I and III.
      Morphological examination was performed with Hematoxylin and Eosin staining (H&E) for histological changes of liver fibrosis.

Statistical analysis
The ILD values of collagen types I and III were analyzed by one-way ANOVA. The statistics were calculated by software SPSS 7.0 for Windows. The data are expressed as mean ±S. E. M. Values of P<0.05 were considered statistically significant.

RESULTS
In vitro expression and secretion of active FLAG-tagged rat collagenase
After in vitro transfection of plasmid in NIH 3T3 cells, the transcription of recombinant collagenase gene was confirmed by RT-PCR amplification of 652 bp cDNA fragment from cells transfected with pCMV-RC-F, but not from cells transfected with control plasmid pTargeTM (Figure 2). This product was of the size expected from mRNA of the tagged collagenase. Further demonstration of transfected gene expression was performed by Western blot analysis using anti-FLAG McAb. The immunoreactive band at about Mr 55 000 was observed in the culture supernatant of cells transfected with pcmv-RC-F but not in that with pTargeTM transfection or in culture medium alone (Figure 3). Collagenase activities were also found around the Mr 55 000 in gelatin zymogram analysis of the culture supernatant of pcmv-RC-F transfected cells and still could be observed after 1:64 dilution. A weak activity of collagenase was also observed in the culture supernatant of pTargeTM transfected cells but was almost undetectable after 1:2 dilution. No enzyme activity of Mr 55 000 collagenase could be detected in culture medium alone (Figure 4).

Figure 2 RT-PCR assay of the mRNA expression of recombinant collagenase in NIH 3T3 cells. The PCR-amplified 652 bp fragment of recombinant collagenase cDNA derived from their respective mRNA was found in NIH 3T3 cells which were transfected with pCMV-RC-F (lane 1), while no signal was detected in cells which transfected with control plasmid pTarge^TM (lane 2). Lane M is the molecular weight marker (DNA/Hind III, BamH 1).

Figure 3 Westernblot analysis of the FLAG-tagged rat collagenase expression using mouse anti-FLAG M2 McAb. The immunoreactive band with anti-FLAG M2 McAb at about Mr 55 000 was observed in the culture supernatant of cells transfected with PCMV-RC-F (lane 1) and the supernatant of 1:2 dilution (lane 2). No immunoreactive was found in the supernatant of cells transfected with pTarge^TM (lane 3, 4) or in culture medium alone (lane 5, 6).

Figure 4 Gelatin zymography analysis for the activity of collagenase. The enhanced gelatin degradation activity was found in the culture supernatant of pcmv-RC-F transfected cells (lane 1-7 represent the zymograph of 1:1, 1:2, 1:4, 1:8, 1:16, 1:32, 1:64 diluted solutions of the supernatant) when compared with pTarge^TM transfected cells (lane 10,11 represent the zymograph of 1:2 and 1:1 diluted solutions of the surpernatant). No activity was found at about Mr 55 000 in the culture medium (lane 8, 9).

In vivo expresson of FLAG-tagged rat collagenase in rat livers and its effects on liver fibrosis
The 650bp amplified product was detected in the RT-PCR samples from pCMV-RIC-F plasmid transduced rat groups (C1 and C2 group) but not in the control animal groups (A and B groups) (Figure 5). The 753 bp amplified product by primer IC-UP4 and IC-DP4 which represent the endogenous collagenase gene expression was detected in all samples (Figure 6). In addition to RT-PCR, the expression of exogenous collagenase was observed in C1 and C2 groups by immunostaining with anti-FLAG antibody (Figure 7). Nearly about 30 percent of total cells presented positive signals in C1 and C2 groups, and the distributions of positive signals were found in both the hepatocytes and the perisinusoidal cells.

Figure 5 RT-PCR assay for the expression of recombinant interstitial collagenase in rat livers. The 652bp PCR amplified fragment of recombinant collagenase cDNA which was derived from their respective mRNA could be detected in liver samples from pCMV-RIC-F plasmid transduced rat groups C1 (lane 1, 2) and C2 (lane 3, 4) but not in the normal control group A (lane 5, 6) and disease control group B (lane 7). 335 bp fragment was PCR amplified b-actin cDNA. Lane M was 100 bp-1200 bp DNA marker ladders.

Figure 6 RT-PCR assay for the endogenous expression of collagenase in rat livers. The 753bp PCR-amplified fragment of endogenous collagenase cDNA which was derived from their respective mRNA could be detected in all liver samples from the normal control groups A (lane 1) and disease control group B (lane 4), as well as pCMV-RIC-F plasmid transduced rat groups C1 (lane 3) and C2 (lane 4). 335 bp fragment was PCR amplified b-actin cDNA. Lane M was 100bp-1200bp DNA marker ladders.

Figure 7 Immunohistochemical analysis of the expression of recombinant plasmid with anti-FLAG antibody in pCMV-RIC-F plasmid transduced group C1 (×400). Nearly about 30 percent of total cells presented positive signals. The distributions of positive signals were found in both the hepatocytes and the perisinusoidal cells.

      The accumulation of collagen types I and III in the livers of animals in group B was more severe then that in group C1 and C2 according to the quantitative analysis of the immunohistochemical findings (P<0.05) (Table 2,Figure 8A-D).

Figure 8 Immunohistochemical analysis of collagen types I (A, B) and III (C, D) in livers (×100). The accumulations of collagen in the disease control group (A, C) were more severe than that in the pCMV-RIC-F plasmid transduced C1 group (B, D).

Table 2 Effects of in vivo transfection of FLAG-tagged rat collagenase on the accumulation of collagen type I and III in experimental liver fibrosis

^aP<0.05 when compared with normal control group (group A); ^bP<0.05 when compared with disease control group (group B). ILD: Integral Light Density; N: number of rats in each group


DISCUSSION
In the present study the expression of FLAG-fusion rat collagenase was detected in pCMV-RC-F transfected NIH 3T3 cells and the secreted FLAG-fusion collagenase was found in the culture supernatant. This recombinant collagenase also exhibited enhanced gelatin degradation activity. These results suggest that the construction of recombinant collagenase plasmid is successfully function in vitro and could be used in further study in vivo. NIH 3T3 cell is a cell line of mouse embryonic fibroblasts. The mouse and the rat interstitial collagenase share highly homology when comparison was made between the amino acid sequences of their active forms^[33]. Constitutive expression of collagenase gene had been found in NIH 3T3 cells before^[34]. In our study, the weak activity of collagenase found in the culture supernatant of pTargeTM transfected cells in our gelatin zymography study might reflect this constitutive expression of mouse collagenase. Similar situation may also exist in liver tissues in vivo. Using anti-FLAG McAb we can easily distinct the recombinant rat collagenase that is tagged with FLAG domain from the natural mouse collagenase or the natural rat collagenase.
      Collagen types I and III constituted the main components found in the increase of ECM^{[35, 36]}. It has been proposed that the degradation of collagen types I and III is very important in the reversion of liver fibrosis. Theoretically the degradation of collagen could be enhanced if the expression of active collagenase increases. In this study, it was found that the recombinant plasmid could be delivered to liver by G-PLL and could be expressed in the tissue of liver. It was observed immunohistochemically that there were significant decrease of collagen types I and III deposition after transducing the recombinant collagenase plasmid into fibrostic livers. This suggests that the exogenous collagenase gene was able to degrade collagen.
      Experimental gene therapies of liver cirrhosis have been tried by other research groups with different gene transfer methods and targeted genes^[37-42]. In our study glycosyl-poly-L-lysine was used in the recombinant collagenase gene transfer into the livers since hepatocytes possess receptors that recognize galactose-terminal (asialo-) glycoproteins and thus they are particularly well suited for receptor-mediated methods of gene transfer. In our previous study it was proved that the recombinant plasmid could be delivered to liver and hepatocytes more specifically by G-PLL than lipofectamine^[33]. In the present study it was also found that the positive signals of anti-FLAG McAb binding protein were in the hepatocytes of the rats of C1 and C2 groups. The less amounts of perisinusoidal cells which had positive signals as well might be the activated kupffer cells that had the function of phagocytosis. In addition, the previous study also observed the obvious expression of recombinant FLAG-tagged rat collagenase in liver at 24 h after plasmid transfection and persisting for longer than three weeks^[31]. No detrimental effects of the transfection and expression of plasmid on important organs of normal rats such as liver, lung, heart and kidney were found by monitoring the serum levels of alanine transaminase, aspartic transaminase and creatinine and by observing the histological manifestation of these organs before and after transfection. These results indicated that the in vivo transfection of recombinant collagenase in liver that was mediated by glycosyl-poly-L-lysine was functionally expressed in liver and safe for other tissues.
      The regulation of collagenase activity was affected by multiple factors^{[43, 44]}. These include regulation of gene-transcription and protein-biosynthesis by cytokines or other factorsm, transformation of proenzymes into active forms, the influence of specific or non-specific inhibitors on the activity of activated enzyme. Some studies have shown that the level of tissue inhibitor of metalloproteinase-1 (TIMP-1), which is a specific inhibitor of metalloproteinase, became very high during progressive liver fibrosis^[45-49]. However the changes of regulation mechanisms such as the expression of TIMP-1 after collagenase gene transduction are still unknown. Whether the treatment effect on liver fibrosis by transferring an antisense gene of TIMP-1 is better than directly transferring collagenase gene as it was performed in this study worth further investigation.
      In summary, the exogenous FLAG-tagged rat collagenase can be transferred by a recombinant plasmid and is expressed functionally in NIH3T3 cells and in a rat liver fibrosis model. As the result demonstrated that in vivo transduction of exogenous FLAG-tagged rat collagenase reduced liver fibrosis, this may stimulate the effort for which, the new therapeutic strategies in the management of liver fibrosis through regulation of collagenase activity and/or its inhibitors.

Acknowledgements
We gratefully acknowledge professor John J. Jeffrey (Departments of Biochemistry and Medicine, Albany Medical Center, USA) for his kind provision of rat collagenase UMR5.4 plasmid. Dr Shouming Wen (Air Force General Hospital of PLA, Beijing, China) for his supply of galactosyl-poly-L-lysine. Dr. Wei-tian Liu and Dr. Lin-Xun Duan(GenWay Biotech Inc Suite E2, Welsh Commons, PA 19454, USA) for the helping construction of plasmid. We also gratefully thank Dr. Arkady Mak, Dr. M. W. L. Koo and Professor M. A. Zern for their critical review of the manuscript.

REFERENCES
1    Friedman SL. The cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N Engl J Med 1993; 323:1828-1835
2    Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992; 14: 455-463
3    Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem
      Hoppe Seyler 1995; 376: 345-355
4    Varghese S, Rydziel S, Jeffrey JJ, Canalis E. Regulation of interstitial collagenase expression and collagen degradation by
      retinoic acid in bone cells. Endocrinology 1994; 134: 2438-2444
5    Sires UI, Schmid TM, Fliszar CJ, Wang ZQ, Gluck SL, Welgus HG. Complete degradation of type X collagen requires the
      combined action of interstitial collagenase and osteoclast-derived cathepsin-B. J Clin Invest 1995; 95: 2089-2095
6    Nikkari ST, OBrien KD, Ferguson M, Hatsukami T, Welgus HG, Alpers CE, Clowes AW. Interstitial collagenase (MMP-1)
      expression in human carotid atherosclerosis. Circulation 1995; 92: 1393-1398
7    Arthur MJP. Collagenases and liver fibrosis. J Hepatol 1995; 22 (Suppl. 2): 43-48
8    Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145-2154
9    Sodek J, Overall CM. Matrix metalloproteinases in periodontal tissue remodelling. Matrix Suppl 1992; 1: 352-362
10  Okazaki I, Watanabe T, Hozawa S, Arai M, Maruyama K. Molecular mechanism of the reversibility of hepatic fibrosis: with
      special reference to the role of matrix metalloproteinases. J Gastroenterol Hepatol 2000; 15(Suppl.):D26-D32
11  Scott JE, Bosworth TR, Cribb AM, Gressner AM. The chemical morphology of extracellular matrix in experimental rat liver
      fibrosis resembles that of normal developing connective tissue. Virchows Arch 1994; 424: 89-98
12  Kovalszky I. Fibrogenesis in the liver fibrosis, cirrhosis. Orv Hetil 1993; 134: 59-64
13  Defour JF, Delellis R, Kaplan MM. Regression of hepatic fibrosis in hepatic fibrosis in hepatitis C with long-term interferon
      treatment. Dig Dis Sci 1998; 43: 2573-2576
14  Dufour JF, Delellis R, Kaplan MM. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann intern Med 1997; 127: 981-985
15  Fort J, Pilette C, Veal N, Oberti F, Gallois Y, Douay O, Rosenbaum J, Cales P. Effects of long-term administration of interferon
      alpha in two models of liver fibrosis in rats. J Hepatol 1998; 29: 263-270
16  Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, Phillips BW, Zhang YK, Urbanski SL. Altered
      balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
      Am J Pathol 1998; 153: 1895-1902
17  Watanabe T, Niioka M, Hozawa S, Kameyama K, Hayashi T, Aria M, Ishikawa A, Maruyama K, Okazaki I. Gene expression of
      interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride.
      J Hepatol 2000; 33: 224-235
18  Lichtinghagen R, Breitenstein K, Arndt B, Kubacher T, Boer KHW. Comparison of matrix metalloproteinase expression in
      normal and cirrhotic human liver. Virchows Arch 1998; 432: 153-158
19  Murawaki Y, Ikuta Y, Idobe Y, Kawasaki H. Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis.
      J Gastrol Hepatol 1999; 14: 138-145
20  Maruyama K, Feinman L, Fainsilber Z, Nakano M, Okazaki I, Lieber CS. Mammalian collagenase increases in early alcoholic
      liver disease and decreases with cirrhosis. Life Sci 1982; 30: 1379-1384
21  Perez-Tamayo R, Montfort I, Gonzalez E. Collagenolytic activity in experimental cirrhosis of the liver.
      Exp Mol Pathol 1987; 47: 300-308
22  Gimeez A, Pare A, AlieS, Camps J, Deulofeu R, Caballeria J, Rodes J. Fibrogenic and collagenolytic activity in
      carbon-tetrachloride-injured rats: beneficial effects of zinc administration. J Hepatol 1994; 21: 292-298
23  Murawaki Y, Koda M, Yamada S, Kawasaki H, Shima H, Burkhardt H. Serum collagenase activity in patients with chronic liver
      disease. J Hepatol 1993; 18: 328-334
24  Murawaki Y, Kawasaki H, Burkhardt H. Serum collagenase activity in chronic liver diseases.
      Pathol Res Pract 1994; 190: 929-933
25  Quinn CO, Scott DK, Brinckerhoff CE, Matrisian LM, Jeffrey JJ, Partridge NC. Rat collagenase cloning, amino acid sequence
      comparison, and parathyroid hormone regulation in osteoblastic cells. J Biol Chem 1990; 265: 22342-22348
26  Brizzard BL, Chubet RG, Vizard DL. Immunoaffinity purification of FLAG epitope-tagged bacterial alkaline phosphatase using
      a novel monoclonal antibody and peptide elution. Biotechniques 1994; 16: 730-735
27  Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: Detection of picogram quantities of gelatinases. Anal Biochem
      1994; 218: 325-329
28  Tyagi SC, Matsubara L, Weber KT. Direct extraction and estimation of collagenase (s) activity by zymography in microquantities
      of rat myocardium and uterus. Clin Biochem 1993; 26: 191-198
29  Perales JC, Ferkol T, Beegen H, Ratnoff OD, Hanson RW. Gene transfer in vivo: sustained expression and regulation of genes
      introduced into the liver by receptor-targeted uptake. Proc Natl Acad Sci USA 1994; 91: 4086-4090
30  Nishikawa M, Takemura S, Takakura Y, Hashida M. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of
      the pharmacokinetics of plasmid DNA/galactosylated poly (L-lysine) complexes by controlling their physicochemical properties.
      J Pharmacol Exp Ther 1998; 287: 408-415
31  Yang C, Wang J, He B, Liu J, Guo J. Glyco-poly-L-lysine is better than liposomal delivery of exogenous genes to rat liver.
      World J Gastroenterol 2000; 6: 526-531
32  Nudel U, Zakut R, Shani M, Neuman S, Levy Z, Yaffe D. The nucleotide sequence of the rat cytoplasmic beta-actin gene.
      Nucleic Acids Res 1983; 11: 1759-1771
33  Henriet P, Rousseau GG, Eeckhout Y. Cloning and sequencing of mouse collagenase cDNA divergence of mouse and rat
      collagenases from the other mammalian collagenases. FEBS L 1992; 310: 175-178
34  Aho S, Rouda S, Kennedy SH, Qin H, Tan EM. Regulation of human interstitial collagenase (matrix metalloproteinase-1)
      promoter activity by fibroblast growth factor. Eur J Biochem 1997; 247: 503-510
35  Rojkind M. Role of metalloproteinases in liver fibrosis. Alcohol Clin Exp Res 1999; 23: 934-939
36  Arthur MJ. Degradation of matrix proteins in liver fibrosis. Pathol Res Pract 1994; 190: 825-833
37  Garcia-Banuelos J, Siller-Lopez F, Miranda A, Aguilar LK, Aguilar-Cordova E, Armendariz-Borunda J. Cirrhotic rat livers with
      extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion.
      Gene Ther 2002; 9: 127-134
38  Salgado S, Garcia J, Vera J, Siller F, Bueno M, Miranda A, Segura A, Grijalva G, Segura J, Orozco H, Hernandez-Pando R,
      Fafutis M, Aguilar LK, Aguilar-Cordova E, Armendariz-Borunda J. Liver cirrhosis is reverted by urokinase-type plasminogen
      activator gene therapy. Mol Ther 2000; 2: 545-551
39  Rudolph KL, Chang S, Millard M, Schreiber-Agus N, DePinho RA. Inhibition of experimental liver cirrhosis in mice by telomerase
      gene delivery. Science 2000; 287: 1253-1258
40  Ukei T, Kaneda Y, Tsutui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto E, Fujimoto J.
      Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999; 5: 226-230
41  Qi Z, Atsuchi N, Ooshima A, Takeshita A, Ueno H. Blockage of type beta transforming growth factor signaling prevents liver
      fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA 1999; 96: 2345-2349
42  Ueno H, Sakamoto T, Nakamura T, Qi Z, Astuchi N, Takeshita A, Shimizu K, Ohashi H. A soluble transforming growth factor
      beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum Gene Ther 2000; 11: 33-42
43  DeCarlo AA Jr, Windsor LJ, Bodden MK, Harber GJ, Birkedal Hansen B, Birkedal Hansen H. Activation and novel processing
      of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis.
      J Dent Res 1997; 76: 1260-1270
44  Schwartz JD, Monea S, Marcus SG, Patel S, Eng K, Galloway AC, Mignatti P, Shamamian P. Soluble factor(s) released from
      neutrophils activates endothelial cell matrix metalloproteinase-2. J Surg Res 1998; 76: 79-85
45  Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ. Expression of tissue inhibitor of metalloproteinase 1 and 2 is
      increased in fibrotic human liver. Gastroenterology 1996; 110: 821-831
46  Murawaki Y, Ikuta Y, Idobe Y, Kitamura Y, Kawasaki H. Tissue inhibitor of metalloproteinase-1 in the liver of patients with
      chronic liver disease. J Hepatol 1997; 26: 1213-1219
47  Dudas J, Kovalszky I, Gallai M, Nagy JO, Schaff Z, Knittel T, Mehde M, Neubauer K, Szalay F, Ramadori G. Expression of
      decorin, transforming factor 朾eta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis.
      Am J Clin Pathol 2001; 115: 725-735
48  Lichtinghagen R, Michels D, Haberkorn CI, Arndt B, Bahr M, Flemming P, Manns MP, Boeker KH. Matrix metalloproteinase
      (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver
      during chronic hepatitis C. J Hepatol 2001; 34: 239-247
49  Boeker KH, Haberkorn CI, Michels D, Flemming P, Manns MP, Lichtinghagen R. Diagnostic potential of circulating TIMP-1 and
      MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C. Clin Chim Acta 2002; 316: 71-81

Edited by Zhao M